BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Cantor Fitzgerald
Chinese Patent Office
US Army
Farmers Insurance
Dow
Julphar
Cerilliant
Argus Health
Johnson and Johnson

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,251,895

« Back to Dashboard

Summary for Patent: 6,251,895
Title: Olanzapine dihydrate D
Abstract:The present invention provides the novel Dihydrate D 2-methyl-thieno-benzodiazepine and a formulation therefor.
Inventor(s): Larsen; Samuel Dean (West Lafayette, IN), Nichols; John Richard (Merscyside, GB), Reutzel; Susan Marie (Indianapolis, IN), Stephenson; Gregory Alan (Fishers, IN)
Assignee: Eli Lilly and Company (Indianapolis, IN)
Application Number:08/935,883
Patent Claim Types:
see list of patent claims
Compound; Composition; Formulation; Dosage form; Use; Process;

Drugs Protected by US Patent 6,251,895

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,251,895

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Turkey 9900639 ➤ Subscribe
El Salvador 1997000079 ➤ Subscribe
Slovenia 831097 ➤ Subscribe
Serbia 49597 ➤ Subscribe
Yugoslavia 15499 ➤ Subscribe
Portugal 831097 ➤ Subscribe
Poland 194074 ➤ Subscribe
Poland 332541 ➤ Subscribe
Peru 110298 ➤ Subscribe
New Zealand 334346 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Daiichi Sankyo
Harvard Business School
Fish and Richardson
Cerilliant
Moodys
Merck
Cipla
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot